The authors demonstrate that skin vasoconstriction induced by cigarette smoking in normal volunteers is due to a concomitant enhancement of arginine vasopressin release. The skin blood flow reduction after smoking was more pronounced in the subjects reaching the highest levels of arginine vasopressin, and this effect no longer developed after administration of a specific vasopressin antagonist acting at the vascular site.